CVS Health Co. (NYSE:CVS) Shares Sold by Impax Asset Management Group plc

Impax Asset Management Group plc decreased its position in CVS Health Co. (NYSE:CVS - Free Report) by 4.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 440,979 shares of the pharmacy operator's stock after selling 19,049 shares during the quarter. Impax Asset Management Group plc's holdings in CVS Health were worth $19,796,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. acquired a new stake in CVS Health during the third quarter worth approximately $25,000. Ridgewood Investments LLC lifted its holdings in shares of CVS Health by 255.7% in the 4th quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator's stock valued at $28,000 after purchasing an additional 450 shares during the last quarter. Stonebridge Financial Group LLC purchased a new position in CVS Health during the 4th quarter worth approximately $28,000. Legacy Investment Solutions LLC purchased a new position in shares of CVS Health during the third quarter worth approximately $31,000. Finally, Reston Wealth Management LLC acquired a new position in CVS Health in the third quarter valued at $32,000. Institutional investors and hedge funds own 80.66% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have weighed in on CVS shares. Cantor Fitzgerald raised CVS Health from a "neutral" rating to an "overweight" rating in a research report on Wednesday, February 12th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a "hold" rating to a "buy" rating and set a $66.00 price objective on the stock in a research note on Tuesday, December 3rd. Truist Financial lifted their target price on shares of CVS Health from $60.00 to $76.00 and gave the company a "buy" rating in a report on Thursday, February 13th. Royal Bank of Canada cut their price target on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. Finally, UBS Group dropped their target price on CVS Health from $62.00 to $59.00 and set a "neutral" rating on the stock in a research report on Tuesday, February 11th. Four investment analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $69.83.

Insider Transactions at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, with a total value of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at approximately $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.24% of the company's stock.

CVS Health Price Performance

NYSE:CVS traded up $1.37 during trading hours on Friday, reaching $65.85. 10,474,843 shares of the company traded hands, compared to its average volume of 12,550,715. CVS Health Co. has a 1-year low of $43.56 and a 1-year high of $80.75. The stock has a market cap of $83.02 billion, a P/E ratio of 17.99, a P/E/G ratio of 0.98 and a beta of 0.61. The firm's 50-day moving average is $53.90 and its 200-day moving average is $56.40. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60.

CVS Health (NYSE:CVS - Get Free Report) last announced its earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. Equities research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.04%. The ex-dividend date of this dividend was Thursday, January 23rd. CVS Health's dividend payout ratio is presently 72.68%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.